288 related articles for article (PubMed ID: 17368865)
1. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
Jolles S
Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
[No Abstract] [Full Text] [Related]
3. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.
Sami N; Bhol KC; Razzaque Ahmed A
Clin Immunol; 2002 Jan; 102(1):59-67. PubMed ID: 11781068
[TBL] [Abstract][Full Text] [Related]
4. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
Sami N; Qureshi A; Ahmed AR
Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
[TBL] [Abstract][Full Text] [Related]
5. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases.
Harman KE; Black MM
Br J Dermatol; 1999 May; 140(5):865-74. PubMed ID: 10354024
[TBL] [Abstract][Full Text] [Related]
6. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.
Engineer L; Bhol KC; Ahmed AR
J Am Acad Dermatol; 2000 Dec; 43(6):1049-57. PubMed ID: 11100022
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune bullous diseases.
Rye B; Webb JM
Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
[TBL] [Abstract][Full Text] [Related]
8. Mucocutaneous features of autoimmune blistering diseases.
Weinberg MA; Insler MS; Campen RB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Nov; 84(5):517-34. PubMed ID: 9394385
[TBL] [Abstract][Full Text] [Related]
9. Emerging treatment for epidermolysis bullosa acquisita.
Engineer L; Ahmed AR
J Am Acad Dermatol; 2001 May; 44(5):818-28. PubMed ID: 11312431
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
[TBL] [Abstract][Full Text] [Related]
11. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.
Jolles S
Clin Exp Dermatol; 2001 Mar; 26(2):127-31. PubMed ID: 11298100
[TBL] [Abstract][Full Text] [Related]
12. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.
Bernard P; Vaillant L; Labeille B; Bedane C; Arbeille B; Denoeux JP; Lorette G; Bonnetblanc JM; Prost C
Arch Dermatol; 1995 Jan; 131(1):48-52. PubMed ID: 7826096
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
[TBL] [Abstract][Full Text] [Related]
14. Vulvar involvement in autoimmune bullous diseases.
Marren P; Wojnarowska F; Venning V; Wilson C; Nayar M
J Reprod Med; 1993 Feb; 38(2):101-7. PubMed ID: 8445600
[TBL] [Abstract][Full Text] [Related]
15. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy.
Gordon KB; Chan LS; Woodley DT
Br J Dermatol; 1997 Mar; 136(3):415-20. PubMed ID: 9115929
[TBL] [Abstract][Full Text] [Related]
16. New immunomodulating drugs in autoimmune blistering diseases.
Korman NJ
Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
[TBL] [Abstract][Full Text] [Related]
17. [Bullous autoimmune diseases of the oral mucosa].
Vaillant L
Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune blistering skin diseases in childhood.
Marinović B; Jukić IL
Acta Dermatovenerol Croat; 2002 Mar; 10(1):33-7. PubMed ID: 12137729
[TBL] [Abstract][Full Text] [Related]
20. Dermatological uses of high-dose intravenous immunoglobulin.
Jolles S; Hughes J; Whittaker S
Arch Dermatol; 1998 Jan; 134(1):80-6. PubMed ID: 9449914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
